Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and...
11 KB (1,025 words) - 06:31, 23 July 2024
Disease (GvHD). In 2013, Osiris sold its MSC drug and associated patents to Mesoblast of Australia and the drug was renamed Ryoncil. Osiris had spent more than...
12 KB (1,199 words) - 13:51, 12 October 2024
(GvHD). Also known as remestemcel-L, Prochymal was sold to Australia-based Mesoblast in 2013 at which time its brand name was changed to Ryoncil. It is an...
3 KB (365 words) - 15:54, 8 April 2023
Biotherapeutics Intra-Cellular Therapies Kallyope Kyras Therapeutics Lucerna Mesoblast Microlin Bio Mispro Biotech Motif BioSciences Lixte Biotechnology Ohr...
20 KB (1,295 words) - 22:15, 2 November 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
12 KB (963 words) - 06:59, 26 September 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
32 KB (2,506 words) - 03:59, 30 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
5 KB (283 words) - 02:39, 17 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
14 KB (1,346 words) - 10:40, 30 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
7 KB (545 words) - 07:15, 10 August 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
21 KB (2,024 words) - 04:14, 22 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
16 KB (1,336 words) - 15:31, 20 September 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
11 KB (1,064 words) - 04:54, 2 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
13 KB (981 words) - 00:46, 22 September 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
21 KB (1,914 words) - 14:50, 9 October 2024
blood cell counts, and is stockpiled for use in radiation incidents. Mesoblast planned in 2004 to use G-CSF to treat heart degeneration by injecting...
27 KB (3,152 words) - 03:12, 29 September 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
25 KB (2,454 words) - 10:46, 19 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
22 KB (1,823 words) - 21:29, 25 August 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
8 KB (507 words) - 08:48, 16 February 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
3 KB (227 words) - 21:25, 14 April 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
11 KB (974 words) - 08:13, 12 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
7 KB (493 words) - 16:40, 29 September 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
14 KB (1,401 words) - 08:02, 10 August 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
9 KB (845 words) - 15:41, 30 September 2024
stem cell drug to be approved for a systemic disease. In January 2016, Mesoblast released results of a phase 2 clinical trial on 241 children with acute...
39 KB (4,442 words) - 15:41, 17 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
4 KB (431 words) - 21:49, 19 March 2023
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
3 KB (256 words) - 03:54, 15 September 2024
9: 8–18. doi:10.1016/j.jot.2017.02.002. PMC 5822958. PMID 29662795. "Mesoblast files spinal fusion IND". Australian Life Scientist. 2006-11-27. Archived...
26 KB (3,142 words) - 13:50, 6 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
17 KB (1,173 words) - 01:22, 25 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
9 KB (692 words) - 02:08, 31 October 2024
Clinuvel Pharmaceuticals Cochlear CSL Fisher & Paykel Healthcare Healius Mesoblast Nanosonics Polynovo Pro Medicus Ramsay Health Care ResMed Sonic Healthcare...
13 KB (1,024 words) - 21:30, 16 September 2024